APA

Roussel M., Moreau P., Huynh A., Mary J., Danho C., Caillot D., Hulin C., Fruchart C., Marit G., Pégourié B., Lenain P., Araujo C., Kolb B., Randriamalala E., Royer B., Stoppa A., Dib M., Dorvaux V., Garderet L., Mathiot C., Avet-Loiseau H., Harousseau J. & Attal M. (20100121). Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM). : Blood.

Chicago

Roussel Murielle, Moreau Philippe, Huynh Anne, Mary Jean-Yves, Danho Clotaire, Caillot Denis, Hulin Cyrille, Fruchart Christophe, Marit Gérald, Pégourié Brigitte, Lenain Pascal, Araujo Carla, Kolb Brigitte, Randriamalala Edouard, Royer Bruno, Stoppa Anne-Marie, Dib Mammoun, Dorvaux Véronique, Garderet Laurent, Mathiot Claire, Avet-Loiseau Hervé, Harousseau Jean-Luc and Attal Michel. 20100121. Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM). : Blood.

Harvard

Roussel M., Moreau P., Huynh A., Mary J., Danho C., Caillot D., Hulin C., Fruchart C., Marit G., Pégourié B., Lenain P., Araujo C., Kolb B., Randriamalala E., Royer B., Stoppa A., Dib M., Dorvaux V., Garderet L., Mathiot C., Avet-Loiseau H., Harousseau J. and Attal M. (20100121). Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM). : Blood.

MLA

Roussel Murielle, Moreau Philippe, Huynh Anne, Mary Jean-Yves, Danho Clotaire, Caillot Denis, Hulin Cyrille, Fruchart Christophe, Marit Gérald, Pégourié Brigitte, Lenain Pascal, Araujo Carla, Kolb Brigitte, Randriamalala Edouard, Royer Bruno, Stoppa Anne-Marie, Dib Mammoun, Dorvaux Véronique, Garderet Laurent, Mathiot Claire, Avet-Loiseau Hervé, Harousseau Jean-Luc and Attal Michel. Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM). : Blood. 20100121.